The US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Eli Lilly and Incyte’s baricitinib to treat Covid-19 with or without remdesivir. In November last year, the FDA granted an...
A large real-world study in more than one million people has found a low incidence...
Brazil’s health agency Anvisa has provisionally suspended the permit for the import and supply of...
A study conducted in South Korea has shown that inoculation with a first dose of...
The US Government has procured another 200 million doses of the Pfizer-BioNTech Covid-19 vaccine, taking...
Moderna has signed an additional agreement with Taiwan to supply 20 million doses of its Covid-19 vaccine and updated variant booster vaccine candidate, if approved. The deal, which requires Moderna…
Pfizer and BioNTech have entered a letter of intent with South Africa-based The Biovac Institute for the manufacture of their Covid-19 vaccine to be supplied in the African Union. Biovac…
Roche and Regeneron Pharmaceuticals have received approval from Japan’s Ministry of Health, Labour and Welfare for Ronapreve to treat mild to moderate Covid-19. The drug is a combination of two…
The European Medicines Agency (EMA) has commenced the review of Sobi’s Kineret (anakinra) to treat Covid-19 in adults who are suffering from pneumonia and are at risk of severe respiratory…
Pfizer and BioNTech have secured priority review designation from the US Food and Drug Administration (FDA) for the biologics license application (BLA) of their Covid-19 vaccine in people aged 16…
The Coalition for Epidemic Preparedness Innovations and COVAX partners are setting up a ‘marketplace’ that will match sellers and buyers of vital production supplies, in turn expediting worldwide manufacturing of…
© Copyright Verdict Media Limited 2021
